Aggressive treatment of early rheumatoid arthritis: recognizing the window of opportunity and treating to target goals.

The American journal of managed care

Volumn 16, Issue 9 Suppl, 2010, Pages

  Resman Targoff, Beth H ^a   Cicero, Marco P ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT;

COST BENEFIT ANALYSIS; DISEASE COURSE; ECONOMICS; HUMAN; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TIME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; HUMANS; REMISSION INDUCTION; RISK ASSESSMENT; TIME FACTORS;

EID: 79960102442     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Review

References (0)